ÂÜÀòÂÒÂ×

Glenn Saldanha is the Chairman and Managing Director of Glenmark Pharmaceuticals Ltd. He joined in 1998 as Director and took over as Managing Director and CEO in 2001. As Chairman and Managing Director of Glenmark, Glenn oversees all operations of the organization. During his tenure, he transformed Glenmark into a truly global organization with revenues of more than $1 billion and a commercial presence in more than 50 countries. Under his leadership, Glenmark has evolved from a generics business into a research-driven and innovation-led organization. He holds a bachelor’s degree in pharmacy from Mumbai University in India and has a master’s degree in business administration from the Leonard Stern School of Business at New York University. Prior to Glenmark, he worked with Eli Lilly, USA and PricewaterhouseCoopers, USA.